Skip to main content

Clene Inc.

For the period ended Dec 31, 2024. Filed Mar 24, 2025.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2024 · Filed Mar 24, 2025

CLNN$4.41+0.7%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Consolidated Statements of Stockholders’ Equity (Deficit)

(In thousands, except share amounts)

Common Stock · Additional Paid-In Capital · Accumulated Deficit · Accumulated Other Comprehensive Income (Loss) · Total Stockholders’ Equity (Deficit)
Shares · Amount
Balances at December 31, 20223,737,921$1$196,252$(193,219)$203$3,237
Issuance of common stock2,681,533—45,574——45,574
Issuance of equity-classified warrants——4,970——4,970
Stock-based compensation expense——9,117——9,117
Issuance of common stock upon vesting of restricted stock awards1,630—————
Unrealized gain on available-for-sale securities————1616
Foreign currency translation adjustment————(20)(20)
Net loss———(49,504)—(49,504)
Balances at December 31, 20236,421,084$1$255,913$(242,723)$199$13,390
Issuance of common stock1,609,222—7,310——7,310
Issuance of equity-classified pre-funded warrants——1,894——1,894
Exercise of stock options41,090—124——124
Exercise of pre-funded warrants17,626—————
Stock-based compensation expense——7,953——7,953
Issuance of common stock upon vesting of restricted stock awards543—————
Unrealized loss on available-for-sale securities————(1)(1)
Foreign currency translation adjustment————(127)(127)
Net loss———(39,400)—(39,400)
Balances at December 31, 20248,089,565$1$273,194$(282,123)$71$(8,857)
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.